Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells11The authors have declared a conflict of interest.H. Suzuki, Richard L. Miller, Binghe Wang et al.|Journal of Investigative Dermatology|2000Cited by 281
In Vitro and In Vivo Expression of Interleukin-1α and Tumor Necrosis Factor-α mRNA in Pemphigus Vulgaris: Interleukin-1α and Tumor Necrosis Factor-α are Involved in AcantholysisClaudio Feliciani, Daniel N. Sauder, Paola Toto et al.|Journal of Investigative Dermatology|2000Cited by 182
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational studyMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi et al.|Expert Opinion on Biological Therapy|2020Cited by 43
Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: Data from the DA‐COVID‐19 registryAndrea Chiricozzi, Clara De Simone, Marco Galluzzo et al.|Allergy|2021Cited by 37
Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in ItalyMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi et al.|Journal of the European Academy of Dermatology and Venereology|2020Cited by 32